Avastin Plus Radiotherapy in Elderly Patients With Glioblastoma

Sponsor
University of Zurich
Study ID
NCT01443676
Phase
PHASE2
Status
Completed

Conditions

Eligibility Criteria

Sex
ALL
Age
65 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Bevacizumab — DRUG
    Bevacizumab will be added to radiotherapy
  • Radiation therapy — RADIATION
    Radiation therapy

Study Details

The purpose of this study is to explore the efficacy of bevacizumab combined with radiotherapy compared with radiotherapy alone in the treatment of newly diagnosed glioblastoma in the elderly. * Trial with medicinal product

Key Dates

First listed
Sep 30, 2011
Start date
Oct 31, 2011
Status verified
Oct 2016
Primary completion
Aug 31, 2015
Completion
Aug 31, 2016

Study Design

Enrollment
75 participants (actual)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT

Arms

  • Active Comparator: Radiotherapy
    Radiotherapy
  • Experimental: Radiotherapy plus Bevacizumab
    Radiotherapy plus Bevacizumab

Primary Outcome Measure

median overall survival [ Time Frame: 1 year ]

Related Studies